The abstract is read at the publisher; the summary is JClub's.
In prostate cancer cells, SAL-driven AR signaling upregulates CD44-DT, which suppresses SAL-induced senescence by enabling PCNA/AR-dependent p21 degradation and proliferation.
- Why it matters: AR-driven progression and SAL-induced senescence are linked, but the molecular lncRNA that connects AR activity to the senescence–proliferation switch is unclear.
- What they did: They used transcriptome, ATAC-seq, and ChIP-seq to show AR recruitment to the first intron of the CD44 locus, then combined CD44-DT knockdown/overexpression with AP-1 inhibition to test senescence effects.
- The result: CD44-DT physically interacts with PCNA and AR to promote p21 degradation and downstream AKT-p70S6K and Rb hyperphosphorylation, and an engineered chimeric ncRNA AR-degrader downregulates CD44-DT while potently inducing apoptosis.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.